Invention Grant
US07691808B2 Use of Slurp-1 for treating diseases related to acetylcholine receptor dysfunction
有权
使用Slurp-1治疗与乙酰胆碱受体功能障碍有关的疾病
- Patent Title: Use of Slurp-1 for treating diseases related to acetylcholine receptor dysfunction
- Patent Title (中): 使用Slurp-1治疗与乙酰胆碱受体功能障碍有关的疾病
-
Application No.: US11516874Application Date: 2006-09-06
-
Publication No.: US07691808B2Publication Date: 2010-04-06
- Inventor: Fabrice Chimienti , Ronald Hogg , Marcel Huber , Daniel Bertrand , Daniel Hohl
- Applicant: Fabrice Chimienti , Ronald Hogg , Marcel Huber , Daniel Bertrand , Daniel Hohl
- Applicant Address: CH Coinsins, Vaud
- Assignee: Merck Serono SA
- Current Assignee: Merck Serono SA
- Current Assignee Address: CH Coinsins, Vaud
- Agency: Mintz, Levin, Cohn, Ferris, Glovsky, and Popeo P.C.
- Agent Ivor R. Elrifi, Esq.
- Main IPC: A61K38/19
- IPC: A61K38/19 ; C07K14/52
Abstract:
Disclosed herein are compositions and methods for the treatment or prevention of neurological disorders. Also disclosed are compositions and methods for the treatment or prevention of skin pathologies. The invention further discloses compositions and methods for the modulation of acetylcholine receptor activity. Antibodies generated against SLURP-1 and related proteins are also included.
Public/Granted literature
- US20070219130A1 Slurp-1 compositions and methods of use thereof Public/Granted day:2007-09-20
Information query
IPC分类:
